Archive

Latest KFF Health News Stories

Choosing Between Death And Deportation

KFF Health News Original

What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.

Vermont Legislators Pass A Drug Importation Law. So What?

KFF Health News Original

The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.

Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.

Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be

KFF Health News Original

Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.

California Hospital Giant Sutter Health Faces Heavy Backlash On Prices

KFF Health News Original

In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.

Will We Still Be Relevant ‘When We’re 64’?

KFF Health News Original

Older adults often feel invisible as their interactions with younger people dwindle and hardly anyone seems to seek their advice. To make matters worse, studies link loneliness to weaker immune systems and poorer physical health.

Primero fue la marihuana… ¿y ahora los hongos alucinógenos?

KFF Health News Original

Siguiendo los pasos de la marihuana, Oregon y Colorado impulsan la legalización de hongos alucinógenos cuya sustancia activa, la psilocibina, podría ayudar a superar la depresión y la ansiedad.

Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws

KFF Health News Original

A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.

First, Marijuana. Are Magic Mushrooms Next?

KFF Health News Original

Advocates in Oregon and Denver are pushing ballot measures to allow possession of mushrooms containing the hallucinogenic ingredient psilocybin, as new research shows it may be useful in treating depression and anxiety. Supporters of a measure to decriminalize magic mushrooms in California ended their effort late last month.